A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

This study has been terminated.
(Initial Principal Investigator left Moffitt)
Millennium Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
First received: August 3, 2006
Last updated: November 21, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)